BIO vs PROV · rev $2.58B vs P/E 18, $106.9M cap
BIO (BIO) versus Provident Financial Holdings Inc (PROV) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Provident Financial Holdings Inc (PROV) is a banks - regional company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
PROV does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. PROV currently screens at market cap $106.9M and trailing P/E 18.4.
Not investment advice. Open the BIO and PROV stock pages for the full models.
Not investment advice.